Valuation : DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 20.67B 3.07B 2.65B 2.48B 2.27B 4.27B 294B 4.28B 29.45B 11.49B 148B 11.53B 11.28B 491B P/E 2026 *
13.9x
P/E 2027 * 12x
Enterprise Value 17.33B 2.58B 2.22B 2.08B 1.9B 3.58B 246B 3.59B 24.69B 9.63B 124B 9.67B 9.46B 412B EV / Sales 2026 *
0.58x
EV / Sales 2027 * 0.53x
Free-Float
34.77%
Yield 2026 *
5.23%
Yield 2027 * 5.78%
1 day+2.43%
1 week+2.77%
Current month-3.71%
1 month-3.66%
3 months+11.69%
6 months-7.30%
Current year+3.01%
1 week 17.33
Extreme 17.33
18.68
1 month 17.33
Extreme 17.33
19.99
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
27.1
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 28/02/2019
Director of Finance/CFO 44 10/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 16/07/2013
Director/Board Member 63 08/08/2016
Chairman 48 28/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
+2.43%+2.77%+5.95%-29.95% 3.07B
-0.16%-5.12%-41.22%-16.16% 14.92B
0.00%-3.53%-41.54%-32.66% 6.48B
+1.76%+2.04%-14.66%-5.29% 6.45B
-0.48%-4.39%-4.59%-24.03% 4.12B
-0.37%+0.32%-18.77%-39.34% 3.25B
-0.21%-3.96%-46.46%-27.86% 2.91B
+1.39%+3.44%-13.27%-3.92% 2.62B
-0.72%-2.29%+41.72% - 2.35B
-0.96%-0.69%-14.74%+16.93% 1.53B
Average +0.27%-0.36%-14.76%-18.03% 4.77B
Weighted average by Cap. +0.28%-1.69%-23.80%-19.21%

Financials

2026 *2027 *
Net sales 29.67B 4.41B 3.8B 3.56B 3.25B 6.13B 422B 6.15B 42.28B 16.5B 213B 16.56B 16.2B 706B 32.83B 4.88B 4.2B 3.94B 3.6B 6.78B 466B 6.8B 46.77B 18.25B 235B 18.32B 17.92B 781B
Net income 1.49B 222M 191M 179M 164M 308M 21.2B 309M 2.13B 830M 10.7B 833M 815M 35.49B 1.73B 257M 221M 207M 189M 357M 24.55B 358M 2.46B 961M 12.39B 964M 943M 41.09B
Net Debt -3.34B -496M -428M -401M -366M -690M -47.45B -692M -4.76B -1.86B -23.95B -1.86B -1.82B -79.42B -3.4B -505M -435M -408M -373M -702M -48.29B -704M -4.84B -1.89B -24.38B -1.9B -1.86B -80.82B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
28/08/26 CN¥18.15 +2.43% 8,745,957
27/08/26 CN¥17.72 -2.90% 8,880,795
26/08/26 CN¥18.25 -0.87% 8,852,328
25/08/26 CN¥18.41 +6.05% 13,450,221
24/08/26 CN¥17.36 -1.70% 6,050,105
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
18.15CNY
Average target price
25.00CNY
Spread / Average Target
+37.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock